These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35932557)

  • 1. Platinum-based nanocomposites loaded with MTH1 inhibitor amplify oxidative damage for cancer therapy.
    Song Q; Yang W; Deng X; Zhang Y; Li J; Xing X; Chen W; Liu W; Hu H; Zhang Y
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112715. PubMed ID: 35932557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
    Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
    Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cepharanthine synergizes with photodynamic therapy for boosting ROS-driven DNA damage and suppressing MTH1 as a potential anti-cancer strategy.
    Yang ZY; Li LG; Xiong YL; Chen NN; Yu TT; Li HT; Ren T; You H; Wang X; Li TF; Wang MF; Hu J
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103917. PubMed ID: 38042236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
    Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
    Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
    Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
    Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese-Based Nanoplatform As Metal Ion-Enhanced ROS Generator for Combined Chemodynamic/Photodynamic Therapy.
    Wang P; Liang C; Zhu J; Yang N; Jiao A; Wang W; Song X; Dong X
    ACS Appl Mater Interfaces; 2019 Nov; 11(44):41140-41147. PubMed ID: 31603650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier Free Photodynamic Synergists for Oxidative Damage Amplified Tumor Therapy.
    Li XY; Deng FA; Zheng RR; Liu LS; Liu YB; Kong RJ; Chen AL; Yu XY; Li SY; Cheng H
    Small; 2021 Oct; 17(40):e2102470. PubMed ID: 34480417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of iridium-based nanocomposite with catalase activity for cancer phototherapy.
    Wu H; Jiang Q; Luo K; Zhu C; Xie M; Wang S; Fei Z; Zhao J
    J Nanobiotechnology; 2021 Jul; 19(1):203. PubMed ID: 34233696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D Copper(II) Metalated Metal-Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity.
    Chen Z; Wu Y; Yao Z; Su J; Wang Z; Xia H; Liu S
    ACS Appl Mater Interfaces; 2022 Oct; 14(39):44199-44210. PubMed ID: 36165392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
    Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
    Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy.
    Cai X; Luo Y; Song Y; Liu D; Yan H; Li H; Du D; Zhu C; Lin Y
    Nanoscale; 2018 Dec; 10(48):22937-22945. PubMed ID: 30500027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
    Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of oxidative stress with a hyperthermia-enhanced chemodynamic process and MTH1 inhibition for sequential tumor nanocatalytic therapy.
    Song Q; Zhang Y; Deng X; Zhao H; Zhang Y; Li J; Chen W; Hu H; Zhang Y
    J Mater Chem B; 2023 May; 11(17):3836-3850. PubMed ID: 36976579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yolk-shell Fe
    Xu Z; Chen J; Li Y; Hu T; Fan L; Xi J; Han J; Guo R
    J Colloid Interface Sci; 2022 Dec; 628(Pt A):1033-1043. PubMed ID: 35970129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor.
    Chen Y; Yang Y; Du S; Ren J; Jiang H; Zhang L; Zhu J
    ACS Appl Mater Interfaces; 2023 Aug; 15(30):35884-35894. PubMed ID: 37487181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
    Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
    ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy.
    Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y
    Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
    Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
    Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.